Burley CEMK-9 overexpresses a SAT and OASTL gene, whereas Burley TRI-2 harbors extra copies of SAT , GSH1 , and PCS genes
What to know Eli Lilly announced a $6 billion investment in a manufacturing campus in northern Alabama to boost production of its next-generation medicines for obesity and metabolic diseases
That said, the animal research is genuinely interesting and points toward several areas worth continued investigation
Standard fingertip application remains the recommended everyday method
Eingun James Song, MD, FAAD, Co-Chief Medical Officer and Director of Clinical Research at Frontier Dermatology in Seattle, WA, agrees
The company has not publicly confirmed a submission date, but its quarterly investor calls have consistently described retatrutide as a "late-stage pipeline priority." Lilly could also pursue a pre-NDA meeting with the FDA, where the agency provides informal guidance on what the application should contain